NDC 50228-461
Carbidopa and Levodopa 50 mg / 200 mg tablet, extended release
On the label: ScieGen Pharmaceuticals, Inc..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| ScieGen Pharmaceuticals, INC. | Hauppauge, NY, United States | Makes it and tests it | Problems found, fixed voluntarilyMay 15, 2026 · 15 inspections, 1 with FDA action |
Product details
- Generic drug
- Carbidopa and Levodopa: every company that makes it
- Form
- tablet, extended release, oral
- Strength
- 50 mg / 200 mg
- Approval
- ANDA ANDA214091
- On the market since
- Oct 5, 2021
- Package NDCs
50228-461-0150228-461-1050228-461-30- Official label
- DailyMed (National Library of Medicine), updated Jun 1, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?